General Abiraterone triplet therapy improves long-term survival in metastatic prostate cancerBy Healthcare Propulsion StaffOctober 25, 20260 Adding abiraterone to standard treatment provides a lasting survival benefit for men whose prostate cancer has already spread at diagnosis,…
